A major advance in cancer research is occurring with the use of nanobodies to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently lost in several types of tumors, resulting uncontrolled https://bookmarkfame.com/story21781230/mini-antibodies-revive-the-p53-protein-the-promising-pathway-for-malignant-management